The real concern is there is no info about the result of the...

The real concern is there is no info about the result of the "clinical trial". We all know that the trial was watered down to seeking feedback from doctors handling the early access scheme. So, it was not a proper trial at all. However, there should be information about it by now even in simple form as anecdotal comments from the doctors. However, there is only silence. The concern here is that the hard capsule is a dud. There is no gain over the soft capsule format. Or it is actually worse than the soft capsule format. The share price has not moved above 16c for quite a number of weeks. This is a real concern. They also mention R&D but there is no info on what they are doing.